» Articles » PMID: 27480093

Propofol Prevents Hippocampal Neuronal Loss and Memory Impairment in Cerebral Ischemia Injury Through Promoting PTEN Degradation

Overview
Journal J Mol Neurosci
Date 2016 Aug 3
PMID 27480093
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroprotective effect of propofol against cerebral ischemia injury was widely investigated. However, its mechanisms remain unclear. Phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) signaling pathway is supposed as a cell survival pathway, and phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a negative regulator of AKT phosphorylation. Whether PTEN was involved in the protective effect of propofol against cerebral ischemia injury was not elucidated. In this study, the function of PTEN in the acute phase of cerebral ischemia injury was investigated. Our data showed that propofol promoted the PTEN degradation in the acute phase of cerebral ischemia injury and concurrently activated AKT phosphorylation. The increase of ubiquitinated PTEN caused by cerebral ischemia injury were degraded in propofol-pretreated rats. Moreover, we evidenced that proteasome activity was stimulated in propofol-treated rats. These data pointed that PTEN degradation was facilitated in the acute phase after propofol treatment possibly through activating ubiquitin-proteasome system. Therefore, we applied PTEN inhibitor-bpV before cerebral ischemia injury. Like propofol, bpV pretreatment also mitigated cerebral ischemia injury-induced cell loss in CA1 region and memory impairment. Taken together, our data suggest that PTEN degradation is neuroprotective against cerebral ischemia injury and propofol facilitates PTEN degradation to prevent hippocampal neuronal loss and memory deficit in cerebral ischemia injury.

Citing Articles

Mechanistic exploration of ubiquitination-mediated pathways in cerebral ischemic injury.

Khanra S, Singh S, Singh T Mol Biol Rep. 2024; 52(1):22.

PMID: 39607439 DOI: 10.1007/s11033-024-10123-5.


Anesthetics in pathological cerebrovascular conditions.

Hou Y, Ye W, Tang Z, Li F J Cereb Blood Flow Metab. 2024; 45(1):32-47.

PMID: 39450477 PMC: 11563546. DOI: 10.1177/0271678X241295857.


Research progress of propofol in alleviating cerebral ischemia/reperfusion injury.

Zheng H, Xiao X, Han Y, Wang P, Zang L, Wang L Pharmacol Rep. 2024; 76(5):962-980.

PMID: 38954373 DOI: 10.1007/s43440-024-00620-6.


G-CSF improved the memory and dendritic morphology impairments in the hippocampal CA1 pyramidal neurons after brain ischemia in the male rats.

Sarkala H, Jahanshahi M, Dolatabadi L, Namavar M Metab Brain Dis. 2023; 38(8):2573-2581.

PMID: 37728699 DOI: 10.1007/s11011-023-01286-4.


Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer's Disease.

Kumar M, Bansal N Mol Neurobiol. 2021; 59(1):354-385.

PMID: 34699027 DOI: 10.1007/s12035-021-02611-7.


References
1.
Zhao J, Qu Y, Wu J, Cao M, Ferriero D, Zhang L . PTEN inhibition prevents rat cortical neuron injury after hypoxia-ischemia. Neuroscience. 2013; 238:242-51. DOI: 10.1016/j.neuroscience.2013.02.046. View

2.
Endersby R, Baker S . PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene. 2008; 27(41):5416-30. DOI: 10.1038/onc.2008.239. View

3.
Kuo C, Lin Y, Tang N, Cheng C, Hsieh C . Electric stimulation of the ears ameliorated learning and memory impairment in rats with cerebral ischemia-reperfusion injury. Sci Rep. 2016; 6:20381. PMC: 4742903. DOI: 10.1038/srep20381. View

4.
Caldeira M, Salazar I, Curcio M, Canzoniero L, Duarte C . Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?. Prog Neurobiol. 2013; 112:50-69. DOI: 10.1016/j.pneurobio.2013.10.003. View

5.
Kim A, Johnston S . Temporal and geographic trends in the global stroke epidemic. Stroke. 2013; 44(6 Suppl 1):S123-5. DOI: 10.1161/STROKEAHA.111.000067. View